Deep brain stimulation (DBS) is a relatively novel treatment in advanced Parkinson's disease (PD). Functional magnetic resonance imaging (fMRI) is a useful technique for examining the effects of DBS both within the basal ganglia and its cortical connectivity. There are technical difficulties in imag
Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson’s disease
✍ Scribed by A. Lokkegaard; L. M. Werdelin; L. Regeur; M. Karlsborg; S. R. Jensen; E. Brødsgaard; F. F. Madsen; M. N. Lonsdale; L. Friberg
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 250 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Both pallidotomy and deep brain stimulation (DBS) have been proven to be effective in suppressing levodopa-induced dyskinesias (LID). The effects of pallidal stereotactic surgery on parkinsonian features have, however, been less consistent. To supplement existing knowledge of globus pallidus (GP) p
Deep brain stimulation of the subthalamic nucleus is an accepted treatment for the motor complications of Parkinson's disease. The therapeutic mechanism of action remains incompletely understood. Although the results of deep brain stimulation are similar to the results that can be obtained by lesion
## Abstract To determine whether the degree to which a patient with Parkinson's disease expects therapeutic benefit from subthalamic nucleus–deep brain stimulation (STN‐DBS) influences the magnitude of his or her improved motor response, 10 patients with idiopathic Parkinson's and bilateral STN‐DBS
## Abstract This study examined whether deep brain stimulation (DBS) would affect the contrast sensitivity (CS) curve in patients with PD. CS was tested in 12 nondemented PD patients treated with bilateral subthalamic nucleus DBS on and off stimulation and medications. Neither stimulation condition
## Abstract We evaluated body weight changes in patients with Parkinson's disease (PD) after electrode implantation for deep brain stimulation (DBS) in the subthalamic nucleus (STN) in relation to clinical improvement. Thirty PD patients who received STN DBS were included (22 men, 8 women; mean age